Avoro Capital Advisors LLC Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$792.0B
Holdings
43
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (43 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —IMMUNOMEDICS INC | 10,488,076 | $92.6B | 11.69% | |
| 2 | —KITE PHARMA INC | 806,750 | $83.6B | 10.56% | |
| 3 | AM6AMICUS THERAPEUTICS INC | 6,180,956 | $60.3B | 7.61% | Call |
| 4 | —TESARO INC | 400,403 | $56.0B | 7.07% | |
| 5 | BMRNBIOMARIN PHARMACEUTICAL INC | 500,789 | $45.5B | 5.74% | |
| 6 | —MEDICINES CO | 1,309,100 | $42.2B | 5.33% | Call |
| 7 | —DERMIRA INC | 1,325,000 | $38.6B | 4.88% | |
| 8 | —TELIGENT INC | 4,130,800 | $37.8B | 4.77% | |
| 9 | ARRYEURARRAY BIOPHARMA INC | 4,675,376 | $35.5B | 4.49% | Call |
| 10 | IOVAIOVANCE BIOTHERAPEUTICS INC | 4,151,343 | $30.5B | 3.85% | |
| 11 | ASNDASCENDIS PHARMA | 990,924 | $27.5B | 3.47% | |
| 12 | GBTUSDGLOBAL BLOOD THERAPEUTICS INC | 860,000 | $23.5B | 2.97% | |
| 13 | PCRXPACIRA PHARMACEUTICALS INC | 465,818 | $22.2B | 2.81% | |
| 14 | ACADACADIA PHARMACEUTICALS INC | 614,200 | $17.1B | 2.16% | |
| 15 | —AVEO PHARMACEUTICALS INC | 6,632,452 | $14.7B | 1.86% | |
| 16 | VNDAVANDA PHARMACEUTICALS INC | 902,146 | $14.7B | 1.86% | |
| 17 | CLVSEURCLOVIS ONCOLOGY INC | 140,700 | $13.2B | 1.66% | |
| 18 | ASMBASSEMBLY BIOSCIENCES INC | 607,162 | $12.5B | 1.58% | |
| 19 | AGENEURAGENUS INC | 3,183,828 | $12.4B | 1.57% | |
| 20 | AERIEURAERIE PHARMACEUTICALS INC | 230,842 | $12.1B | 1.53% | |
| 21 | BCRXBIOCRYST PHARMACEUTICALS INC | 1,953,525 | $10.9B | 1.37% | |
| 22 | CPRXCATALYST PHARMACEUTICALS INC | 3,804,745 | $10.5B | 1.33% | |
| 23 | NBIXNEUROCRINE BIOSCIENCES INC | 219,500 | $10.1B | 1.27% | |
| 24 | MRTXEURMIRATI THERAPEUTICS INC | 2,275,401 | $8.3B | 1.05% | |
| 25 | —ALIMERA SCIENCES INC | 5,891,581 | $8.2B | 1.03% | |
| 26 | VCYTVERACYTE INC | 907,596 | $7.6B | 0.95% | |
| 27 | GBYSANGAMO THERAPEUTICS INC | 800,000 | $7.0B | 0.89% | |
| 28 | —CASCADIAN THERAPEUTICS INC | 1,821,248 | $6.8B | 0.85% | |
| 29 | —VIVEVE MEDICAL INC | 795,500 | $5.7B | 0.72% | |
| 30 | ARGXARGENX SE | 215,597 | $4.6B | 0.58% | |
| 31 | NVROEURNEVRO CORP | 50,000 | $3.7B | 0.47% | |
| 32 | —FORTRESS BIOTECH INC | 603,657 | $2.9B | 0.36% | |
| 33 | CLLSCELLECTIS - ADR | 85,689 | $2.2B | 0.28% | |
| 34 | PTCTPTC THERAPEUTICS | 120,000 | $2.2B | 0.28% | |
| 35 | —AXOVANT SCIENCES LTD | 82,087 | $1.9B | 0.24% | |
| 36 | —PERNIX THERAPEUTICS HOLDINGS INC | 6,000,000 | $1.9B | 0.23% | |
| 37 | SPYSPDR S&P 500 ETF | 250,000 | $1.5B | 0.18% | Put |
| 38 | —NEURODERM LTD | 44,516 | $1.3B | 0.17% | |
| 39 | SRNESORRENTO THERAPEUTICS INC | 416,230 | $832.0M | 0.11% | |
| 40 | —ONCOBIOLOGICS INC | 683,531 | $684.0M | 0.09% | |
| 41 | —OVASCIENCE INC | 313,316 | $489.0M | 0.06% | |
| 42 | —ONCOBIOLOGICS INC - WARRANT A | 233,333 | $40.0M | 0.01% | |
| 43 | —ONCOBIOLOGICS INC - WARRANT B | 233,333 | $22.0M | 0.00% |